The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.
 
Tomono Kawase
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Medtronic; Medtronic; Medtronic; Medtronic; MSD; MSD; MSD; MSD; Olympus; Olympus; Olympus; Olympus; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Stryker; Stryker; Stryker; Stryker; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
 
Noboru Kobayashi
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Ryohei Kawabata
No Relationships to Disclose
 
Tsuyoshi Takahashi
Research Funding - SBI Pharmaceuticals; SBI Pharmaceuticals; SBI Pharmaceuticals; SBI Pharmaceuticals
 
Makoto Yamasaki
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose